BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 26945387)

  • 21. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
    Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
    Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma.
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Am J Hematol; 2014 Jul; 89(7):726-31. PubMed ID: 24711255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The utility of restaging bone marrow biopsy in PET-negative patients with diffuse large B-cell lymphoma and baseline bone marrow involvement.
    Jackson AE; Smeltzer JP; Habermann TM; Jones JM; Burnette B; Ristow K; Wiseman GA; Macon WR; Nowakowski GS; Witzig TE
    Am J Hematol; 2014 Sep; 89(9):865-7. PubMed ID: 24823914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of three evaluation methods of ¹⁸F-FDG PET/CT in detecting bone marrow infiltration in patients with newly diagnosed diffuse large B-cell lymphoma].
    Bai J; Zhang Y; Duan M; Li J; Cao X; Cai H; Zhuang J; Chen M; Zhou D; Zhu Z; Zhang W
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):489-92. PubMed ID: 26134014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of 2-(fluorine-18) Fluoro-2-deoxy-D-glucose Positron Emission Tomography/Computed Tomography in Initial Staging and Bone Marrow Involvement Prediction in Patients with Newly Diagnosed Lymphoma in Correlation with Bone Marrow Study.
    Krishna S; Ravina M; Nanda S; Lukose TT; Moideen A; Bansal H; Dasgupta S; Kote R
    Indian J Nucl Med; 2024; 39(1):10-17. PubMed ID: 38817719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow FDG-PET/CT in Hodgkin lymphoma revisited: do imaging and pathology match?
    Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Nievelstein RA; de Klerk JM
    Ann Nucl Med; 2015 Feb; 29(2):132-7. PubMed ID: 25348549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
    Kim M; Ahn SY; Ahn JS; Song GY; Jung SH; Lee JJ; Kim HJ; Lee JH; Shin MG; Song SY; Yang DH
    J Korean Med Sci; 2022 Jan; 37(1):e2. PubMed ID: 34981678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High SUV uptake on FDG-PET/CT predicts for an aggressive B-cell lymphoma in a prospective study of primary FDG-PET/CT staging in lymphoma.
    Ngeow JYY; Quek RHH; Ng DCE; Hee SW; Tao M; Lim LC; Tan YH; Lim ST
    Ann Oncol; 2009 Sep; 20(9):1543-1547. PubMed ID: 19474116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone Marrow Involvement in Malignant Lymphoma: Evaluation of Quantitative PET and MRI Biomarkers.
    Asenbaum U; Nolz R; Karanikas G; Furtner J; Woitek R; Simonitsch-Klupp I; Raderer M; Mayerhoefer ME
    Acad Radiol; 2018 Apr; 25(4):453-460. PubMed ID: 29199055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Utility and prognostic value of PET/CT, bone marrow biopsy and aspirate for detection of bone marrow involvement in diffuse large B-cell lymphoma].
    Jiang XY; Zou DM; Zhang YQ; Wang Z; Zhang W; Zhou DB; Zhang Y
    Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):663-667. PubMed ID: 36709151
    [No Abstract]   [Full Text] [Related]  

  • 31. Systematic review and meta-analysis on the diagnostic performance of FDG-PET/CT in detecting bone marrow involvement in newly diagnosed Hodgkin lymphoma: is bone marrow biopsy still necessary?
    Adams HJ; Kwee TC; de Keizer B; Fijnheer R; de Klerk JM; Littooij AS; Nievelstein RA
    Ann Oncol; 2014 May; 25(5):921-7. PubMed ID: 24351400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is it sufficient to evaluate bone marrow involvement in newly diagnosed lymphomas using
    Hao B; Zhao L; Luo NN; Ruan D; Pang YZ; Guo W; Fu H; Guo XY; Luo ZM; Wu J; Chen HJ; Wu H; Sun L
    BMC Cancer; 2018 Nov; 18(1):1192. PubMed ID: 30497426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information.
    Nakajima R; Moskowitz AJ; Michaud L; Mauguen A; Batlevi CL; Dogan A; Schöder H
    Blood Adv; 2020 Apr; 4(8):1812-1823. PubMed ID: 32343798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [18F]Fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma.
    Purz S; Mauz-Körholz C; Körholz D; Hasenclever D; Krausse A; Sorge I; Ruschke K; Stiefel M; Amthauer H; Schober O; Kranert WT; Weber WA; Haberkorn U; Hundsdörfer P; Ehlert K; Becker M; Rössler J; Kulozik AE; Sabri O; Kluge R
    J Clin Oncol; 2011 Sep; 29(26):3523-8. PubMed ID: 21825262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET/CT Assessment of Follicular Lymphoma and High Grade B Cell Lymphoma - Good Correlation with Clinical and Histological Features at Diagnosis.
    Novelli S; Briones J; Flotats A; Sierra J
    Adv Clin Exp Med; 2015; 24(2):325-30. PubMed ID: 25931367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FDG PET for Evaluation of Bone Marrow Status in T-Cell Lymphoma.
    Koh Y; Lee JM; Woo GU; Paeng JC; Youk J; Yoon SS; Kim I; Kang KW
    Clin Nucl Med; 2019 Jan; 44(1):4-10. PubMed ID: 30371574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic value of FDG-PET in the detection of bone marrow involvement in patients with diffuse large B-cell lymphoma].
    Zhang X; Fan W; Lin XP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):832-5. PubMed ID: 19176040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone involvement in patients with lymphoma: the role of FDG-PET/CT.
    Schaefer NG; Strobel K; Taverna C; Hany TF
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):60-7. PubMed ID: 17021808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma.
    Abe Y; Kitadate A; Usui Y; Narita K; Kobayashi H; Miura D; Takeuchi M; Oʼuchi E; Oʼuchi T; Matsue K
    Clin Nucl Med; 2019 May; 44(5):e336-e341. PubMed ID: 30889000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy and prognostic impact of FDG PET/CT and biopsy in bone marrow assessment of follicular lymphoma at diagnosis: A Nation-Wide cohort study.
    Ródenas-Quiñonero I; Chen-Liang T; Martín-Santos T; Salar A; Fernández-González M; Celades C; Navarro JT; Martínez-Garcia AB; Andreu R; Balaguer A; Martin García-Sancho A; Baile M; López-Jiménez J; Marquet-Palomanes J; Teruel AI; Terol MJ; Benet C; Frutos L; Navarro JL; Uña J; Suarez M; Cortes M; Contreras J; Ruiz C; Tamayo P; Mucientes J; Sopena-Novales P; Reguilón-Gallego L; Sánchez-Blanco JJ; Pérez-Ceballos E; Jerez A; Ortuño FJ
    Cancer Med; 2023 Mar; 12(6):6536-6546. PubMed ID: 36373169
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.